16,387 reports of this reaction
3.3% of all Cosentyx reports
#3 most reported adverse reaction
PAIN is the #3 most commonly reported adverse reaction for Cosentyx, manufactured by Novartis Pharmaceuticals Corporation. There are 16,387 FDA adverse event reports linking Cosentyx to PAIN. This represents approximately 3.3% of all 494,338 adverse event reports for this drug.
Patients taking Cosentyx who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is moderately reported among Cosentyx users, representing a notable but not dominant share of adverse events.
In addition to pain, the following adverse reactions have been reported for Cosentyx:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 16,387 FDA reports for Cosentyx. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 3.3% of all adverse event reports for Cosentyx, making it one of the most commonly reported side effect.
If you experience pain while taking Cosentyx, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.